Introduction: Pulmonary arterial hypertension (PAH) remains a progressive and life-threatening condition despite advances with vasodilator-based therapies (1). Traditional drugs such as endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, and prostacyclin analogues primarily address vasoconstriction leaving vascular remodelling lar
Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
Patient with History of Atrial Fibrillation
519 Reached3 Likes